Understanding and appreciating overdiagnosis in the PSA era

J Natl Cancer Inst. 2002 Jul 3;94(13):958-60. doi: 10.1093/jnci/94.13.958.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Aged
  • Humans
  • Incidence
  • Male
  • Population Surveillance
  • Prostate-Specific Antigen / blood*
  • Prostatic Neoplasms / blood
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / mortality
  • SEER Program
  • Sensitivity and Specificity
  • Survival Rate
  • United States / epidemiology

Substances

  • Prostate-Specific Antigen